EX vivo intraoperative surgical basal margin analysis in head and neck cancer resection: clinical validation in a clinical collaboration with the university medical center groningen (UMCG),…

Active Project Grant Awarded Last action

Award ID
R01DE033449
Recipient
Awarding agency
Obligated
$3,453,135

Award facts

Assistance listing
93.121 Oral Diseases and Disorders Research
Completion date 52% complete
Place of performance
Chicago, IL 60616, USA

Award details come from USAspending.gov.

Description

EX vivo intraoperative surgical basal margin analysis in head and neck cancer resection: clinical validation in a clinical collaboration with the university medical center groningen (UMCG), netherlands-led by oral and maxillofacial surgeon, DR. Witjes-we will advance and clinically test an intraoperative dual-aperture fluorescence ratio (DAFR) imaging system and an automated data analysis (ADA) approach that can analyze an entire resected-tissue basal margin in 30 min and can only be done for a limited number of resected-tissue locations. The project will specifically focus on improving detection and localization of inadequate (positive and close) basal surgical margins, critical for patient survival. Over 3 million individuals across the globe are diagnosed with head and neck squamous cell carcinoma (HNSCC) each year. At present, surgical intervention is the primary treatment; however, owing to the complexity of the anatomy in the head and neck, >20% of procedures may fail to attain tumor-free surgical basal margins (defined as greater than 5 MM of healthy tissue surrounding the deep edge of the resected tumor). Unfortunately, because of slow resected-tissue processing, patients are often sent home before margins are fully assessed. While some patients can return for RE-resection, for many, health concerns or substantial post-resection reconstruction surgeries make RE-resection infeasible, and radiotherapy and/or chemoradiotherapy is needed. Patients with inadequate margins have 80% chance of survival for patients with free margins and no metastatic disease. Before DAFR imaging and surgery, patients are injected with a fluorescent epidermal growth factor receptor (EGFR)-targeted antibody, and intraoperative DAFR images of resected basal margins are taken and analyzed. Our preliminary results from a proof-of-concept DAFR imaging system indicate almost perfect detection rate of inadequate as well as clear margins. In this project, we propose necessary imaging system upgrades and to develop an automated data analysis to remove the need for clinical expert manual segmentation of images. The proposed approach will be validated and tested against state-of-the-art surgical guidance methods in an 80-patient clinical study at UMCG, in terms of detection and localization of inadequate basal margins through ROC and lroc assessments.

Transactions

Action Obligated Date
Amendment $200,129
Amendment $283,003
Amendment $283,003
Amendment $0
Amendment $0
Amendment $0
Amendment $53,256
Amendment $479,317
Amendment $479,317
Amendment $558,370
Amendment $558,370
Original award $558,370
Show all 12

Subawards

Subrecipient Amount Awarded
Universitair Medisch Centrum Groningen The main objective in this study is to assess the surgical margin of excised HNSCC, using cetuximab- IRDye800CW as a contrast agent, with optical imaging in… $200,129
Universitair Medisch Centrum Groningen The main objective in this study is to assess the surgical margin of excised HNSCC, using cetuximab-IRDye800CW as a contrast agent, with optical imaging in… $280,784

Quick answers

Who received award R01DE033449?

R01DE033449 was awarded to Illinois Institute Of Technology by National Institute of Dental and Craniofacial Research (National Institutes of Health) on April 2, 2024.

How much is award R01DE033449 worth?

$3,453,135 has been obligated on R01DE033449.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award